bioRxivBiophysics
In situ architecture and membrane fusion of SARS-CoV-2 Delta variant
Y. Song, H. Yao, N. Wu, J. Xu, Z. Zhang, C. Peng, S. Li, W. Kong, Y. Chen, M. Zhu, J. Wang, D. Shi, C. Zhao, X. Lu, M. Echavarria Galindo, S. Li
Abstract
Among the current five Variants of Concern, infections caused by the SARS-CoV-2 B.1.617.2 (Delta) variant are often associated with the greatest severity. Despite recent advances on the molecular basis of elevated pathogenicity using recombinant proteins, architecture of intact Delta virions remains veiled. Moreover, molecular evidences for the detailed mechanism of S-mediated membrane fusion are missing. Here we reported the in situ structure and distribution of S on the authentic Delta variant, and discovered invagination in the distinctive Delta architecture. We also captured fusion snapshots from the virus-virus fusion events, provided structural evidences for Deltas attenuated dependency on cellular factors for fusion activation, and proposed a model of S-mediated membrane fusion. Site-specific glycan analysis revealed increased oligomannose-type glycosylation of native Delta S over that of the Wuhan-Hu-1 S. Together, these results disclose distinctive factors of Delta being the most virulent SARS-CoV-2 variant. In BriefCryo-ET of intact SARS-CoV-2 Delta variant revealed its distinctive architecture and captured snapshots of its membrane fusion in action.
- organism: virus
- assay: cryo-EM
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
- Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants
M. McCallum, A. C. Walls, … D. Veesler·bioRxiv·Aug 11, 2021
- SARS-CoV-2 Alpha, Beta and Delta variants display enhanced Spike-mediated Syncytia Formation
M. M. Rajah, M. Hubert, … O. Schwartz·bioRxiv·Jun 11, 2021
- Structure-activity relationships of B.1.617 and other SARS-CoV-2 spike variants
T.-J. Yang, P.-Y. Yu, … S.-T. D. Hsu·bioRxiv·Sep 12, 2021
- Structural impact on SARS-CoV-2 spike protein by D614G substitution
- SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough
P. Mlcochova, S. A. Kemp, … Saliba·bioRxiv·May 8, 2021